Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials
14 Downloads
Fellow & Resident Scientific & Educational Resources
The RELIEF Fellow and Resident Toolkit is an online tool that aims to provide up-to-date information on relevant clinical trials in diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO). Click on one of the options below to learn more about clinical trials in each disease state.
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM).
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2019 | Fellow & Resident | All Rights Reserved | Website by Divigner